• Fosinopril Sodium: Mechanistic Innovation for Translational

  2026-04-21

  Explore how Fosinopril sodium, a third-generation phosphinic acid ACE inhibitor, redefines translational cardiovascular and renal research. This article delivers actionable mechanistic guidance, protocol parameters, and competitive insights, empowering researchers to optimize hypertension and heart failure models with evidence-backed clarity.

• Plk1 Regulates p31comet in Mitotic Checkpoint Disassembly

  2026-04-20

  This study reveals how Polo-like kinase 1 (Plk1) phosphorylates the Mad2-binding protein p31comet, inhibiting its role in the disassembly of mitotic checkpoint complexes. The findings clarify a critical regulatory mechanism for ensuring accurate chromosome segregation during mitosis, with implications for cell cycle research and targeted inhibitor studies.

• Plk1-Mediated Regulation of p31comet in Mitotic Checkpoint D

  2026-04-20

  This study uncovers how Polo-like kinase 1 (Plk1) regulates the action of p31comet in dismantling mitotic checkpoint complexes, a pivotal step for accurate chromosome segregation. By demonstrating Plk1’s phosphorylation of p31comet and its inhibitory effect on mitotic checkpoint complex disassembly, the work provides new mechanistic insight into mitotic progression control and highlights implications for cell cycle research.

• TMEM16F Lipid Scrambling Modulates Ferroptosis and Tumor Imm

  2026-04-19

  Yang et al. uncover TMEM16F as a plasma membrane lipid scramblase that protects tumor cells from ferroptosis by redistributing oxidized phospholipids, thereby reducing membrane tension and damage. Disabling TMEM16F sensitizes tumors to ferroptosis and enhances antitumor immune responses, especially when combined with PD-1 blockade, highlighting a novel strategy for cancer therapy.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-04-18

  This study uncovers that naturally occurring angiotensin peptides, including short C- and N-terminal fragments, markedly enhance binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings bridge cardiovascular peptide research with viral entry mechanisms, providing new perspectives for both pathogenesis studies and therapeutic targeting.

• Applied Uses of (-)-Epigallocatechin Gallate in Biomedical R

  2026-04-17

  (-)-Epigallocatechin gallate (EGCG) stands out as a versatile cell-permeable polyphenol for apoptosis, antiangiogenic, and antiviral research. Explore optimized experimental workflows, real-world troubleshooting, and actionable insights for maximizing EGCG’s impact in cancer chemoprevention and neurodegeneration assays.

• Reliable Cell Assays with (-)-Epinephrine (+)-bitartrate (SK

  2026-04-16

  This article addresses practical laboratory challenges in cell viability, proliferation, and cytotoxicity assays by demonstrating how (-)-Epinephrine (+)-bitartrate (SKU B1358) delivers reproducible, sensitive results as a validated adrenergic receptor agonist. Drawing on real-world scenarios, quantitative data, and literature-backed protocols, it provides candid, collegial guidance for biomedical researchers seeking robust solutions supported by APExBIO’s product quality.

• Diclofenac in Human Organoid Pharmacokinetics: Assay Precisi

  2026-04-15

  Explore Diclofenac as a non-selective COX inhibitor in advanced human organoid-based pharmacokinetic and inflammation signaling pathway research. This article uniquely dissects assay setup, model fidelity, and protocol optimization, bridging chemical and cellular insights for precise anti-inflammatory drug research.

• Bradykinin B2 Receptors Modulate Ileal Peristalsis in Guinea

  2026-04-14

  This study provides the first direct evidence that bradykinin, via B2 receptors, inhibits the peristaltic reflex in the guinea pig ileum. These findings clarify the receptor-specific actions of bradykinin in gastrointestinal motility, with implications for ACE inhibitor research and bradykinin pathway modulation.

• SMYD2 Inhibition Mitigates Renal Fibrosis in Cisplatin-Induc

  2026-04-13

  The referenced study demonstrates that pharmacological inhibition of SMYD2, using agents like AZ505, can significantly reduce renal fibrosis and inflammation in a cisplatin-induced chronic kidney disease (CKD) model. This work uncovers SMYD2 as a critical epigenetic regulator of renal injury and fibrosis, offering new directions for disease mechanism studies and therapeutic exploration.

• RG7388 and the MDM1-p53 Axis: Rewiring Translational Oncolog

  2026-04-13

  This thought-leadership article explores how RG7388, a next-generation, highly selective MDM2 antagonist, enables translational researchers to activate the p53 pathway, induce cancer cell apoptosis, and overcome resistance in wild-type p53 tumor models. Integrating recent biomarker insights—including the pivotal role of MDM1 in modulating chemoradiotherapy sensitivity—this piece provides mechanistic depth, experimental strategy, and guidance for leveraging RG7388 in precision oncology. Strategic comparisons, workflow recommendations, and internal content references position this article as a forward-looking resource beyond typical product summaries.

• Ultra Fast LC–MS/MS for Cefazedone and Etimicin Pharmacokine

  2026-04-12

  This study introduces a validated ultra fast LC–MS/MS method enabling simultaneous quantification of cefazedone and etimicin in beagle dog plasma, supporting rigorous pharmacokinetic investigation of combined antibiotic therapy. The method's sensitivity and specificity advance research on cephalosporin-aminoglycoside co-administration, with implications for optimizing antibacterial regimens.

• EdU Flow Cytometry Assay Kits (Cy5): Technical Protocol & QC

  2026-04-12

  The EdU Flow Cytometry Assay Kits (Cy5) address the need for sensitive, reproducible quantification of S-phase DNA synthesis without harsh denaturation, making them well-suited for multiplexed cell proliferation studies by flow cytometry. This kit is ideal for researchers needing direct, high-integrity detection of DNA replication, but is not designed for applications outside flow cytometry or for fixed-tissue imaging workflows.

• Imatinib Hydrochloride: Optimizing Kinase Inhibition Workflo

  2026-04-11

  Imatinib hydrochloride (STI571 hydrochloride) is a gold-standard tyrosine kinase inhibitor for dissecting v-Abl, c-Kit, and PDGFR signaling in cancer research. This guide delivers evidence-backed protocols, advanced troubleshooting, and novel insights from recent structural biology—empowering researchers to maximize reproducibility and assay sensitivity across CML and GIST models.

• UTP Solution in RNA Amplification: Protocols, Pitfalls, and

  2026-04-11

  APExBIO's UTP Solution (100 mM) delivers unmatched purity and reliability in high-stakes RNA workflows, from in vitro transcription to advanced neurogenetic studies. Discover step-by-step optimizations, troubleshooting tactics, and actionable parameters that translate bench protocols into reproducible breakthroughs.

15930 records 1/1062 page Next 12345 下5页 Last page